1. Home
  2. RES vs OGN Comparison

RES vs OGN Comparison

Compare RES & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RPC Inc.

RES

RPC Inc.

HOLD

Current Price

$6.60

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.38

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RES
OGN
Founded
1984
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
RES
OGN
Price
$6.60
$13.38
Analyst Decision
Hold
Hold
Analyst Count
5
5
Target Price
$5.64
$11.40
AVG Volume (30 Days)
1.6M
5.0M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
2.02%
0.60%
EPS Growth
N/A
N/A
EPS
N/A
0.55
Revenue
$41,919,000,000.00
$6,216,000,000.00
Revenue This Year
$3.29
$0.45
Revenue Next Year
$4.05
$1.67
P/E Ratio
$45.40
$24.28
Revenue Growth
2216.21
N/A
52 Week Low
$4.18
$5.69
52 Week High
$8.16
$13.48

Technical Indicators

Market Signals
Indicator
RES
OGN
Relative Strength Index (RSI) 38.79 74.68
Support Level $6.42 $10.05
Resistance Level $6.85 $13.46
Average True Range (ATR) 0.25 0.05
MACD -0.07 -0.22
Stochastic Oscillator 7.05 47.50

Price Performance

Historical Comparison
RES
OGN

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. Its operating segment includes Technical Services and Support Services. The Technical Services segment, which generates maximum revenue, comprises service lines that generate revenue based on equipment, personnel, or materials at the well site and are closely aligned with completion and production activities of the customers. The Support Services segment comprises service lines that generate revenue from services and equipment offered off the well site and are closely aligned with the customers' drilling activities.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: